NCT01102738

Brief Summary

The investigators will collect daily faecal samples from premature (\<32 weeks) infants in the intensive care unit from the day of birth until they are discharged. By using newly developed molecular detection techniques the investigators aim to define more precisely than has ever previously been attempted, all the species of bacteria present in the faeces. This will enable comparison of the pre-morbid and post-morbid intestinal microbiota (all the bacteria in the gut) in premature neonates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
369

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2010

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 13, 2010

Completed
9 months until next milestone

Study Start

First participant enrolled

January 1, 2011

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2013

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
5.9 years until next milestone

Results Posted

Study results publicly available

May 1, 2020

Completed
Last Updated

May 1, 2020

Status Verified

April 1, 2020

Enrollment Period

2 years

First QC Date

March 31, 2010

Results QC Date

August 8, 2019

Last Update Submit

April 30, 2020

Conditions

Keywords

Premature intestinal microbiotaNecrotizing Enterocolitis

Outcome Measures

Primary Outcomes (1)

  • The Composition of Bacteria Present, Established by Ultra-deep RNA Gene Sequencing, in Pre-morbid Faecal Samples From Neonates With Necrotizing Enterocolitis and Late-onset Bacterial Sepsis.

    Faecal samples were analysed using 16S rRNA gene sequencing to determine the bacterial content present in faecal samples collected from pre term infants prior to the onset of necrotising enterocolitis. Bacteria were identified and relative proportions reported for each faecal sample analysed.

    Maximum of 6 months - serial samples collected from each infant (maximum admission duration 6 months), recruitment opened for 24 months.

Study Arms (1)

Premature babies (<32 weeks)

All premature babies born at less than 32 completed weeks gestation who are admitted to an Imperial College NHS Healthcare Trust Neonatal Intensive Care Unit (St. Mary's Hospital or Queen Charlotte's \& Chelsea Hospital), and whose parents/guardians have given their consent will be eligible to enter the study.

Eligibility Criteria

AgeUp to 32 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Premature babies born at less than 32 completed weeks gestation

You may qualify if:

  • All premature babies born at less than 32 completed weeks gestation who are admitted to an Imperial College NHS Healthcare Trust Neonatal Intensive Care Unit (St. Mary's Hospital or Queen Charlotte's \& Chelsea Hospital), and whose parents/guardians have given their consent will be eligible to enter the study.

You may not qualify if:

  • All babies born at more than 32 completed weeks gestation will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Imperial College London

London, W21PG, United Kingdom

Location

Queen Charlotte's and Chelsea Hospital - NICU

London, United Kingdom

Location

St. Mary's Hospital - Winnicott Baby Unit

London, United Kingdom

Location

Related Publications (2)

  • Shaw AG, Cornwell E, Sim K, Thrower H, Scott H, Brown JCS, Dixon RA, Kroll JS. Dynamics of toxigenic Clostridium perfringens colonisation in a cohort of prematurely born neonatal infants. BMC Pediatr. 2020 Feb 18;20(1):75. doi: 10.1186/s12887-020-1976-7.

  • Sim K, Shaw AG, Randell P, Cox MJ, McClure ZE, Li MS, Haddad M, Langford PR, Cookson WO, Moffatt MF, Kroll JS. Dysbiosis anticipating necrotizing enterocolitis in very premature infants. Clin Infect Dis. 2015 Feb 1;60(3):389-97. doi: 10.1093/cid/ciu822. Epub 2014 Oct 23.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Faecal samples, surplus gut tissue samples (if patient requires bowel resection due to Necrotizing Enterocolitis).

MeSH Terms

Conditions

Enterocolitis, Necrotizing

Condition Hierarchy (Ancestors)

EnterocolitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Results Point of Contact

Title
Dr. Kathleen Sim
Organization
Imperial College London

Study Officials

  • J Simon Kroll, MA BM FRCP

    Imperial College London

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2010

First Posted

April 13, 2010

Study Start

January 1, 2011

Primary Completion

January 1, 2013

Study Completion

June 1, 2014

Last Updated

May 1, 2020

Results First Posted

May 1, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations